Funded by the EU

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101071175. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or European Innovation Council (EIC). Neither the European Union or EIC can be held responsible for them.


Pedro Costa

Dr. Pedro Costa is a researcher, inventor, educator and entrepreneur. He is the founder and CEO/CTO of the company BIOFABICS, which is specialized in the creation of 3D Biotissue Analogues. Before that, he was the coordinator of the world’s first MSc Programme in Biofabrication at Utrecht University, manager of the Utrecht Biofabrication Facility and postdoctoral researcher at the University Medical Center Utrecht (Netherlands).

Dr. Costa can be described as a biologist by training and engineer/maker by heart, given his undergraduate studies in Applied Biology followed by a PhD in Biomedical Engineering where he specialized in the combination of highly automated tools such as 3D (bio)printing and bioreactor technologies in the field of tissue engineering and regenerative medicine. He has previously worked in both academic and industrial environments in places such as Germany (Technical University of Munich), Australia (Queensland University of Technology), Belgium (Materialise NV) and Portugal (University of Minho). Dr. Costa has received several awards for his work, among them the 2014 Translational Award (European Society for Biomaterials) and the 2016 Young Investigator Award (International Society for Biofabrication). In 2018 he was also awarded with a Marie Sklodowska-Curie Individual Fellowship from the European Union’s Horizon 2020 research and innovation programme and in 2020 was selected as a finalist (top 4 in the Innovative Science category) in the European Commission’s Innovation Radar Prize.

Furthermore, Dr. Costa currently acts as expert evaluator, principal investigator and coordinator in several EU-funded research & innovation projects.

Matej Buzgo

Matej Buzgo is the Head of Research and Development of Respilon Group.
He has 15 years experience in nanofiber preparation from biomedical, technical and drug delivery applications. He is the author of more than 30 scientific publications, more than 10 patents and commercialized 5 nanofiber-based products.

Dr. Sundar Pattabiraman

Dr. Sundar Pattabiraman is the CEO/CSO at Geneus Biotech.
He has 13 years of experience with molecular biology and Stem cells. Sundar has a Masters from University of Edinburgh (UK), PhD from Goettingen (Germany) and he completed 1.5 years as a  Post-Doctoral Scientist from the reputed research institute, DZNE (Germany). He has authored articles in peer reviewed journals and is the co-inventor of the Hairoid and the Furoid project.